First, we observed that dams given the selective EP4 antagonist AE3-208 from D15 to D19 of pregnancy (protocol D) had pups with varying degrees of PDA at 4 h of age compared with fully closed DAs in vehicle-treated mice (Supplemental Fig. S3). This evidence concerns the gene PTGER4 and Patent ductus arteriosus.